T. Moran

发表

Calciferol and its relatives. Part 22. A direct total synthesis of vitamin D2 and vitamin D3

P. W. Wright, B. Lythgoe, T. Moran, 1978 .

Structure-based design, synthesis, and biological evaluation of irreversible human rhinovirus 3C protease inhibitors. 8. Pharmacological optimization of orally bioavailable 2-pyridone-containing peptidomimetics.

D. Matthews, P. Rejto, P. W. Rose, 2003, Journal of medicinal chemistry.

Calciferol and its relatives. Part 21. A synthesis of (S)-(Z)-2-(5-hydroxy-2-methylenecyclohexylidene)ethanol

J. Milner, B. Lythgoe, T. Moran, 1978 .

Synthesis of benzoylpyrimidines as antagonists of the corticotropin-releasing factor-1 receptor.

D. Grigoriadis, T. Webb, Chen Chen, 2004, Bioorganic & medicinal chemistry letters.

Mesoionic oxadiazolium-olates and oxatriazolium-olates from aryl isocyanides and nitroform

J. H. Boyer, T. Moran, T. P. Pillai, 1983 .

Design and synthesis of a series of non-peptide high-affinity human corticotropin-releasing factor1 receptor antagonists.

E. D. De Souza, D. Grigoriadis, T. Webb, 1996, Journal of medicinal chemistry.

Alkylation of phosphoramidate and phosphinic amide anions

R. Edmundson, T. Moran, 1970 .

Design and synthesis of irreversible depsipeptidyl human rhinovirus 3C protease inhibitors.

D. Matthews, B. Srinivasan, S. Webber, 2001, Bioorganic & medicinal chemistry letters.

Allylic phosphine oxides as precursors of conjugated dienes of defined geometry

S. Ruston, B. Lythgoe, T. Moran, 1977 .

Allylic phosphine oxides as precursors of dienes of defined geometry: Synthesis of 3-deoxyvitamin D2

S. Ruston, P. W. Wright, B. Lythgoe, 1975 .

Design and Synthesis of a Series of Non-Peptide High-Affinity Human Corticotropin-Releasing Factor1 Receptor Antagonists

C. Chen, D. Grigoriadis, T. Webb, 1997 .